Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Neoplasms 10Prostatic Neoplasms 8Head and Neck Neoplasms 8Colorectal Neoplasms 8Breast Neoplasms 7Motor Activity 6Ovarian Neoplasms 5Rectal Neoplasms 4Oropharyngeal Neoplasms 4Multiple Myeloma 4Endometrial Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Mouth Neoplasms 3Hematologic Neoplasms 3Colorectal Neoplasms, Hereditary Nonpolyposis 3COVID-19 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Pancreatic Neoplasms 2Obesity 2Nasopharyngeal Neoplasms 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 2Leiomyoma 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Hematological Cancer 2Colonic Neoplasms 2Carcinoma, Squamous Cell 2

Interventions

sargramostim 1isatuximab 1alethine 1Surveys and Questionnaires 1Cyclophosphamide 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Monoclonal Gammopathy of Undetermined Significance × Surveys and Questionnaires × Clear all
NCT04727294 2021-08-04

MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

HealthTree Foundation

Unknown
1,500 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Coronavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡